Vanguard Personalized Indexing Management’s Halozyme HALO Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.91M	Sell	29,485 -1,184	-4%	-$83.5K	0.02%	618
2025 Q4	$2.06M	Sell	30,669 -675	-2%	-$45.4K	0.02%	585
2025 Q3	$2.3M	Buy	31,344 +1,715	+6%	+$114K	0.02%	542
2025 Q2	$1.54M	Buy	29,629 +6,717	+29%	+$382K	0.02%	668
2025 Q1	$1.46M	Buy	22,912 +1,420	+7%	+$82.5K	0.02%	612
2024 Q4	$1.03M	Buy	21,492 +617	+3%	+$31.6K	0.02%	765
2024 Q3	$1.19M	Buy	20,875 +164	+0.8%	+$9.4K	0.02%	684
2024 Q2	$1.08M	Buy	20,711 +2,463	+13%	+$108K	0.02%	642
2024 Q1	$742K	Sell	18,248 -1,802	-9%	-$67.6K	0.02%	821
2023 Q4	$741K	Buy	20,050 +9,272	+86%	+$349K	0.02%	797
2023 Q3	$412K	Buy	10,778 +688	+7%	+$28.2K	0.01%	972
2023 Q2	$364K	Sell	10,090 -3,278	-25%	-$112K	0.01%	1033
2023 Q1	$511K	Sell	13,368 -890	-6%	-$41.7K	0.02%	861
2022 Q4	$811K	Buy	14,258 +1,640	+13%	+$84K	0.03%	592
2022 Q3	$499K	Buy	12,618 +7,036	+126%	+$311K	0.02%	787
2022 Q2	$246K	Buy	+5,582	New	+$241K	0.01%	1050